"Pediatric pathologist studies role of microRNAs in deadly Ewing’s sarcoma
Aurora, Colo. (June 30, 2010)—A Colorado cancer researcher has received two grants totaling $280,000 to support his work in understanding the function of microRNAs in Ewing’s sarcoma.
Paul Jedlicka, MD, PhD, member of the University of Colorado Cancer Center Molecular Oncology Program and assistant professor of pathology at the University of Colorado School of Medicine, is one of three University of Colorado scientists to be named inaugural Boettcher Investigators, an award that shares a $700,000 pool of grant money. The program supports early-career biomedical investigators working to make a direct impact on human health.
Jedlicka also received a two-year, $80,000 Young Investigator Award from the Alex’s Lemonade Stand Foundation for Childhood Cancer to continue work on microRNAs identified by his laboratory that may suppress Ewing’s sarcoma tumors. He’ll use the Boettcher Investigator funding to look at other sets of microRNA that may regulate the development of Ewing’s sarcoma."
Link to the University of Colorado Cancer Center posting